faricimab (genetical recombination) 28.8mg 127 vials,satralizumab (genetical recombination) 120mg 2

Tender Notice

Tender Detail
faricimab (genetical recombination) 28.8mg 127 vials,satralizumab (genetical recombination) 120mg 24 vials,ravulizumab (genetical recombination) 300mg 45 vials,epcoritamab (genetical recombination) 48mg 12 vials
Tendering Authority
Tender Category
Other
Publish Date
22 Feb 2025
Deadline
14 Apr 2025
Country
Japan
TenderNews Ref. No.
867317250222-0
Document Fees
Refer Document.
EMD
Refer Document.
Tender Value
Refer Document.
« Previous Tender      Next Tender »

Some of Our Valuable Clients